RNAZ TransCode Therapeutics, Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

TransCode Therapeutics (RNAZ) Stock: Buy, Sell, or Hold?

$1.40
+0.05 (+3.70%) β–²
5d: -12.5% 30d: -16.67% 90d: -59.77%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (63%)
Quality Score
42/100
Position
OVERSOLD
30-Day Fair Range
$1.54 – $1.78
Position: OVERSOLD
Forward P/E & Valuation
-4.2x
Next 12M consensus est.
Wall Street Target
$10.00
+640.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.33 / $1.91
Trend: Strong Downtrend
πŸ’‘Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: RNAZ is down 12.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Get Alerted When RNAZ Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: RNAZ is currently trading at $1.40, which is considered oversold relative to its 30-day fair value range of $1.54 to $1.78.

Technical Outlook: Technically, RNAZ is in a strong downtrend. Immediate support is located at $1.33, while resistance sits at $1.91. The stock is showing strong short-term momentum, up 3.7% recently.

Market Sentiment: RNAZ scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.00 (+640.7%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $1.54 - $1.78
Company Quality Score 42/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 63.2%

Trading Range & Key Levels

30-Day Trading Range $1.54 - $1.78
Current vs Trading Range OVERSOLD
Support Level $1.33
Resistance Level $1.91
Current Trend Strong Downtrend
Technical data as of Nov 11, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (33/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+3.7%)
  • BULLISH: Trading 640.7% below Wall St target ($10.00)
  • WARNING: Composite score 42/100 in the bottom quintile β€” this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -4.22
Wall Street Target $10.00 (+640.7%)
Share RNAZ Analysis

Share this live RNAZ analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (RNAZ)

Bullish 1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 30, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits shows 100.0% bullish sentiment towards $RNAZ with one user expressing optimism about a potential price pump.
Key Retail Themes: Price pump potential
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 4:01 PM ET
Data refreshes hourly during market hours. Next update: 5:01 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for RNAZ.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CYTK
Cytokinetics Inc
STRONG BUY
22 analysts
$107 61 BUY
INSM
Insmed Inc
STRONG BUY
24 analysts
$194 37 SELL
MDGL
Madrigal Pharmaceuticals…
STRONG BUY
19 analysts
$689 56 HOLD
RZLT
Rezolute Inc
STRONG BUY
11 analysts
$10 72 BUY
CRNX
Crinetics Pharmaceutical…
STRONG BUY
17 analysts
$86 46 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive RNAZ Research Pages
RNAZ Technical Chart RNAZ Price Prediction RNAZ Intrinsic Value DCF RNAZ Earnings Date RNAZ Investment Advisor RNAZ Fair Price Analyzer RNAZ Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals